<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: The significance of the mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in TNM staging and prognosis for <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> patients is still controversial </plain></SENT>
<SENT sid="1" pm="."><plain>The aim was to provide a meta-analysis for TNM staging and prognostic features of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: 30 individual case-control studies were finally included into this meta-analysis, involving a total of 444,489 cancer cases and 45,050 mucinous <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, of relations with TNM staging and prognostic features </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Compared to non-mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients, the TNM IV stage accounted for a larger percentage of mucinous <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (OR=1.48, 95%CI 1.28-1.71, POR&lt;0.001) and the prognosis was significantly poor (HR=1.06, 95%CI 1.04-1.08, P&lt;0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>After <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> testing, the results was similar to the holistic approach outcome (HR=1.48, 95%CI 1.35-1.62, P&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: Compared to patients with non-mucinous <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients with later TNM staging make up a big percentage, and mucinous <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is an independent risk factor for poor prognosis </plain></SENT>
</text></document>